Serum zonulin has been proposed as a biomarker for the transition from autoimmunity to inflammatory arthritis, as individuals with PreRA exhibit markedly elevated zonulin levels, and longitudinal analyses indicate that those with concentrations above 10 ng/mL during the preclinical phase face a substantially increased risk of developing RA within one year [16]. This evidence concerns the gene HP and rheumatoid arthritis.